Percutaneous Ethanol Injection Therapy (PEIT) of parathyroid adenoma under ultrasound guidance is individually used as an alternative procedure in management of primary hyperparathyroidism in polymorbid elderly patients with increased surgical risk. The treatment is also suitable for patients who already underwent surgery of the thyroid gland, and any other surgery is associated with a higher risk of postsurgical complications. We present a case of a 92-year-old male patient, who underwent thyroidectomy for papillary thyroid carcinoma three years ago. Part of the regular annual follow-up visits was also ultrasonography, which showed a solitary parathyroid adenoma at the site of the removed thyroid gland. Given the underlying condition, polymorbidity and age of the patient, the PEIT method was successfully used in the therapy. The coincidence of adenoma and papillary thyroid carcinoma is also interesting.

University Hospital Department of Internal Medicine 3 Nephrology Rheumatology and Endocrinology Olomouc Czech Republic

University Hospital Department of Nuclear Medicine Olomouc Czech Republic

Zobrazit více v PubMed

Fraser WD. Hyperparathyroidism. Lancet. 2009;374(9684):145–158. PubMed

Bilezikian JP, Khan AA, Potts JT, Jr Third International Workshop on the Management of Asymptomatic Primary Hyperthyroidism. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab. 2009;94(2):335–339. PubMed PMC

Broulik P, Adamek S, Libansky P, Tvrdom J. Diagnosis and treatment of primary hyperparathyroidism. Interni Med. 2007;9(3):130–132.

Karstrup S, Hegedüs L, Holm HH. Acute change in parathyroid function in primary hyperparathyroidism following ultrasonically guided ethanol injection into solitary parathyroid adenomas. Acta Endocrinol (Copenh) 1993;129(5):377–380. PubMed

Solbiati L, Giangrande A, De Pra L, Bellotti E, Cantù P, Ravetto C. Percutaneous ethanol injection of parathyroid tumors under US guidance: treatment for secondary hyperparathyroidism. Radiology. 1985;155(3):607–610. PubMed

Müller-Gärtner HW, Beil FU, Schneider C, Ringe JD, Greten H. Percutaneous transthyroidal instillation treatment of parathyroid adenoma with ethanol in primary hyperparathyroidism. Dtsch Med Wochenschr. 1987;112(38):1459–1461. PubMed

Charboneau JW, Hay ID, van Heerden JA. Persistent primary hyperparathyroidism: successful ultrasound-guided percutaneous ethanol ablation of an occult adenoma. Mayo Clin Proc. 1988;63(9):913–917. PubMed

Bilezikian JP, Potts JT, Jr, Fuleihan Gel-H, Kleerekoper M, Neer R, Peacock M, Rastad J, Silverberg SJ, Udelsman R, Wells SA. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metab. 2002;87(12):5353–5361. PubMed

Silverberg SJ, Lewiecki EM, Mosekilde L, Peacock M, Rubin MR. Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab. 2009;94(2):351–365. PubMed PMC

Karstrup S, Transbøl I, Holm HH, Glenthøj A, Hegedüs L. Ultrasound-guided chemical parathyroidectomy in patients with primary hyperparathyroidism: a prospective study. Br J Radiol. 1989;62(744):1037–1042. PubMed

Harman CR, Grant CS, Hay ID, Hurley DL, van Heerden JA, Thompson GB, Reading CC, Charboneau JW. Indications, technique, and efficacy of alcohol injection of enlarged parathyroid glands in patients with primary hyperparathyroidism. Surgery. 1998;124(6):1011–1019. PubMed

Cercueil JP, Jacob D, Verges B, Holtzmann P, Lerais JM, Krause D. Percutaneous ethanol injection into parathyroid adenomas: mid- and long-term results. Eur Radiol. 1998;8(9):1565–1569. PubMed

Stratigis S, Stylianou K, Mamalaki E, Perakis K, Vardaki E, Tzenakis N, Katsipi I, Papavasiliou S, Yarmenitis S, Kyriazis J, Daphnis E. Percutaneous ethanol injection therapy: a surgery-sparing treatment for primary hyperparathyroidism. Clin Endocrinol (Oxf) 2008;69(4):542–548. PubMed

Wagner B, Begic-Karup S, Raber W, Schneider B, Waldhäusl W, Vierhapper H. Prevalence of primary hyperparathyroidism in 13387 patients with thyroid diseases, newly diagnosed by screening of serum calcium. Exp Clin Endocrinol Diabetes. 1999;107(7):457–461. PubMed

Morita SY, Somervell H, Umbricht CB, Dackiw AP, Zeiger MA. Evaluation for concomitant thyroid nodules and primary hyperparathyroidism in patients undergoing parathyroidectomy or thyroidectomy. Surgery. 2008;144(6):862–866. PubMed

Linos DA, van Heerden JA, Edis AJ. Primary hyperparathyroidism and nonmedullary thyroid cancer. Am J Surg. 1982;143(3):301–303. PubMed

Milas M, Mensah A, Alghoul M, Berber E, Stephen A, Siperstein A, Weber CJ. The impact of office neck ultrasonography on reducing unnecessary thyroid surgery in patients undergoing parathyroidectomy. Thyroid. 2005;15(9):1055–1059. PubMed

Web portal: GLOBOCAN, IARC. www.globocan.iarc.fr.

Cordeiro AC, Montenegro FL, Kulcsar MA, Dellanegra LA, Tavares MR, Michaluart P, Jr, Ferraz AR. Parathyroid carcinoma. Am J Surg. 1998;175(1):52–55. PubMed

Ulanovski D, Feinmesser R, Cohen M, Sulkes J, Dudkiewicz M, Shpitzer T. Preoperative evaluation of patients with parathyroid adenoma: role of high-resolution ultrasonography. Head Neck. 2002;24(1):1–5. PubMed

Abboud B, Sleilaty G, Rabaa L, Daher R, Abou Zeid H, Jabbour H, Hachem K, Smayra T. Ultrasonography: highly accuracy technique for preoperative localization of parathyroid adenoma. Laryngoscope. 2008;118(9):1574–1578. PubMed

Hara H, Igarashi A, Yano Y, Yashiro T, Ueno E, Aiyoshi Y, Ito K, Obara T. Ultrasonographic features of parathyroid carcinoma. Endocr J. 2001;48(2):213–217. PubMed

Halenka M, Frysak Z, Koranda P, Kucerova L. Cystic parathyroid adenoma within a multinodular goiter: a rare cause of primary hyperparathyroidism. J Clin Ultrasound. 2008;36(4):243–246. PubMed

Nozeran S, Duquenne M, Guyetant S, Rodien P, Rohmer V, Ronceray J, Saint-André JP, Bigorgne JC. [Diagnosis of parathyroid cysts: value of parathyroid hormone level in puncture fluid] Presse Med. 2000;29(17):939–941. PubMed